Novavax, Inc (NASDAQ:NVAX) price on Wednesday, November 13, fall -8.22% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.76. A look at the stock’s price movement, the close in the last trading session was $8.46, moving within
Novavax, Inc (NASDAQ:NVAX) price closed lower on Friday, November 08, and dropping -2.94% below its previous close. A look at the daily price movement shows that the last close reads $9.18, with intraday deals fluctuated between $8.845 and $9.25. The company’s 5Y monthly beta was
Novavax, Inc (NASDAQ:NVAX) concluded the trading at $8.96 on Wednesday, November 06 with with a fall of -5.08% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.44 and 5Y monthly beta
Novavax, Inc (NASDAQ:NVAX) traded at $9.35 at close of the session on Friday, November 01 and made a downward move of -2.71% on its previous day’s price. Looking at the stock we see that its previous close was $9.61 and the beta (5Y monthly) reads
Novavax, Inc. (NASDAQ:NVAX) shares, rose in value, with the stock price down by -2.28% to the previous day’s close as strong demand from buyers drove the stock to $9.84. Actively observing the price movement in the last trading, the stock closed the session at $10.07,
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
